MLICM
VOR icon

Metropolitan Life Insurance Company (MetLife)’s Vor Biopharma VOR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-110
Closed -$6.79K – 2450
2023
Q2 		$6.79K Buy
+110
New +$10K ﹤0.01% 2433
2022
Q1 		– Sell
-313
Closed -$72.7K – 2693
2021
Q4 		$72.7K Hold
313
– – ﹤0.01% 2624
2021
Q3 		$98.1K Buy
+313
New +$93K ﹤0.01% 2528
2021
Q2 		– Sell
-202
Closed -$174K – 2891
2021
Q1 		$174K Buy
+202
New +$171K ﹤0.01% 2120

Other funds holding VOR

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VOR Position: Q3 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Vor Biopharma (VOR) in Q3 2023, closing a stake of 110 shares — an estimated $6.79K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VOR in Q1 2021 and held it in 4 quarters. The position peaked at $174K in Q1 2021. 59 funds tracked by Wall St. Rank hold VOR as of Q3 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Vor Biopharma position as of Q3 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 110 Vor Biopharma shares in Q3 2023, an estimated $6.79K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Vor Biopharma in Q1 2021 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Vor Biopharma position peaked at $174K in Q1 2021.
  • 59 funds tracked by Wall St. Rank held Vor Biopharma as of Q3 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2023, filed 14 Nov 2023.